Bionor Pharma ASA : Synne H Røine, new Chief Financial Officer Begins at Bionor Pharma Medio May

   Bionor Pharma ASA : Synne H Røine, new Chief Financial Officer Begins at
                           Bionor Pharma Medio May

The Appointment Strengthens Bionor Pharma's Management Team and Presence in
the Financial Market

(Oslo, Norway 14 May 2013) Bionor Pharma ASA (OSE: BIONOR) today announced
that Synne H Røine, who was announced 1 March as the Company's new CFO, now
will begin to work at Bionor Pharma.

Synne H Røine (33) has held the position as Chief Financial Officer of Pronova
BioPharma ASA since July 2009, where she has played a key role in the
financial team from the IPO in 2007 to the acquisition of the Company by BASF
in January 2013.

For more information, see the release which was published 1 March 2013
regarding the appointment of Ms. Røine.

Bionor Pharma ASA

Hilde Aalling Syvertsen
-Director Communications & Corporate Affairs

Tel +47 23 01 09 60

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Bionor Pharma ASA via Thomson Reuters ONE
HUG#1701709
 
Press spacebar to pause and continue. Press esc to stop.